國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Placebos and nocebos in headaches

Benedetti, Fabrizio.

Placebos and nocebos in headaches

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Placebos and nocebos in headachesedited by Dimos D. Mitsikostas, Fabrizio Benedetti.
其他作者:	Mitsikostas, Dimos D.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	ix, 142 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	HeadacheTreatment.
電子資源:	https://doi.org/10.1007/978-3-030-02976-0
ISBN:	9783030029760$q(electronic bk.)

Placebos and nocebos in headaches
Placebos and nocebos in headaches[electronic resource] /edited by Dimos D. Mitsikostas, Fabrizio Benedetti. - Cham :Springer International Publishing :2019. - ix, 142 p. :ill., digital ;24 cm. - Headache,2197-652X. - Headache..

1 Headache Classification and Diagnosis -- 2 The burden of headache -- 3 Patient centred approach in headaches -- 4 Unmet needs in headache management -- 5 Mechanisms of pain and headache -- 6 The reward system -- 7 Mechanisms of placebo -- 8 Mechanisms of nocebo -- 9 Placebo in headache treatment -- 10 Nocebo in headache treatment.

This book discusses the role of placebos and nocebos in the treatment of headache disorders. These disorders are usually treatable, but safety and tolerability issues mean that available preventive treatments have often limited success, even in the right hands - one in five patients treated with a migraine preventive pharmaceutical agent discontinues treatment for those reasons. The nocebo effect plays a role here, with patients' negative expectation and previous unpleasant treatment experiences creating negative belief in the treatment's benefits and safety, which in turn limits treatment outcomes and adherence significantly. In RCTs on migraine prevention, one in 20 patients treated with a placebo discontinued treatment because of adverse events, indicating a considerable nocebo effect; the fewer potential adverse events described in the consent form, the smaller the nocebo effect. As such, physicians treating headache sufferers should acknowledge nocebo as a significant cofactor for treatment adherence and failure, and plan techniques to limit the effects, such as patient education and close follow-up. This highly informative and painstakingly presented book provides scientific insights for professionals and scholars with an interest in internal medicine, neurology and pain medicine.

ISBN: 9783030029760$q(electronic bk.)

Standard No.: 10.1007/978-3-030-02976-0doiSubjects--Topical Terms:

522789
Headache
--Treatment.

LC Class. No.: RC392

Dewey Class. No.: 616.8491

Placebos and nocebos in headaches
LDR:02627nmm a2200337 a 4500 001 553860
003 DE-He213
005 20190211141508.0
006 m d
007 cr nn 008maaau
008 191112s2019 gw s 0 eng d
020 $a 9783030029760$q(electronic bk.)
020 $a 9783030029753$q(paper)
024 7 $a 10.1007/978-3-030-02976-0 $2 doi
035 $a 978-3-030-02976-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC392
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.8491 $2 23
090 $a RC392 $b .P697 2019
245 0 0 $a Placebos and nocebos in headaches $h [electronic resource] / $c edited by Dimos D. Mitsikostas, Fabrizio Benedetti.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a ix, 142 p. : $b ill., digital ; $c 24 cm.
490 1 $a Headache, $x 2197-652X
505 0 $a 1 Headache Classification and Diagnosis -- 2 The burden of headache -- 3 Patient centred approach in headaches -- 4 Unmet needs in headache management -- 5 Mechanisms of pain and headache -- 6 The reward system -- 7 Mechanisms of placebo -- 8 Mechanisms of nocebo -- 9 Placebo in headache treatment -- 10 Nocebo in headache treatment.
520 $a This book discusses the role of placebos and nocebos in the treatment of headache disorders. These disorders are usually treatable, but safety and tolerability issues mean that available preventive treatments have often limited success, even in the right hands - one in five patients treated with a migraine preventive pharmaceutical agent discontinues treatment for those reasons. The nocebo effect plays a role here, with patients' negative expectation and previous unpleasant treatment experiences creating negative belief in the treatment's benefits and safety, which in turn limits treatment outcomes and adherence significantly. In RCTs on migraine prevention, one in 20 patients treated with a placebo discontinued treatment because of adverse events, indicating a considerable nocebo effect; the fewer potential adverse events described in the consent form, the smaller the nocebo effect. As such, physicians treating headache sufferers should acknowledge nocebo as a significant cofactor for treatment adherence and failure, and plan techniques to limit the effects, such as patient education and close follow-up. This highly informative and painstakingly presented book provides scientific insights for professionals and scholars with an interest in internal medicine, neurology and pain medicine.
650 0 $a Headache $x Treatment. $3 522789
650 0 $a Placebos (Medicine) $3 667728
650 1 4 $a Internal Medicine. $3 273839
650 2 4 $a Neurology. $3 211583
650 2 4 $a Pain Medicine. $3 276762
700 1 $a Mitsikostas, Dimos D. $3 736983
700 1 $a Benedetti, Fabrizio. $3 701554
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Headache. $3 710582
856 4 0 $u https://doi.org/10.1007/978-3-030-02976-0
950 $a Medicine (Springer-11650)